MBAL Sveti Pantaleimon OOD

The medical center is at the forefront of research into diabetic retinopathy, focusing on the long-term effects of innovative treatments. The center's work is pivotal in understanding how therapies like semaglutide can influence the progression of this condition in individuals with type 2 diabetes.

• Long-term effects of semaglutide
• Standardized ophthalmic assessments
• Post-authorization safety studies

By conducting comprehensive studies, the center aims to mitigate the phenomenon of "early worsening" and improve patient outcomes through validated methodologies.

Specializing in cardiovascular health, the center is dedicated to confirming the efficacy of novel treatments for stable angina pectoris. The research focuses on the anti-anginal effects of T89, providing critical insights into managing chronic conditions.

• Anti-anginal effects of T89
• Chronic stable angina management
• Outcome research studies

Through rigorous clinical trials, the center contributes to the development of effective therapeutic strategies, enhancing the quality of life for patients with stable angina.